Avenues for antifungal drug discovery and development: where to now?

Click to increase image sizeClick to decrease image size

Article highlights

• Description of new antifungal classes under evaluation.

• Reports of new agents from established classes and the utilization of commonly used drugs in patients with different indications.

• Addition of immunotherapy to the antifungal arsenal.

• Dealing with rising antifungal resistance.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties

Reviewer disclosures

A reviewer on this manuscript has disclosed that they are affiliated with Sano Chemicals which is also developing antifungal drugs.

Patient consent statement

This study does not include factors necessitating patient consent.

Additional information

Funding

This paper was not funded.